Trademark: 97043169
Word
ELUVOGUE
Status
Pending
Status Code
732
Status Date
Friday, March 15, 2024
Serial Number
97043169
Mark Type
4000
Filing Date
Friday, September 24, 2021
Published for Opposition
Tuesday, August 2, 2022

Trademark Owner History
AbbVie Biotechnology Ltd - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 16, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2024
Sou Extension 3 Granted
Mar 15, 2024
Sou Extension 3 Filed
Mar 15, 2024
Sou Teas Extension Received
Sep 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2023
Sou Extension 2 Granted
Sep 13, 2023
Sou Extension 2 Filed
Sep 13, 2023
Sou Teas Extension Received
Mar 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2023
Sou Extension 1 Granted
Mar 23, 2023
Sou Extension 1 Filed
Mar 23, 2023
Sou Teas Extension Received
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 27, 2022
Approved For Pub - Principal Register
Jun 27, 2022
Assigned To Examiner
Oct 26, 2021
New Application Office Supplied Data Entered
Sep 28, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24